- Home
- ROIV vs NVMI Comparison
ROIV vs NVMI Comparison
Compare ROIV & NVMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- NVMI
- Stock Information
- Founded
- ROIV 2014
- NVMI 1993
- Country
- ROIV United Kingdom
- NVMI Israel
- Employees
- ROIV N/A
- NVMI N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- NVMI Electronic Components
- Sector
- ROIV Health Care
- NVMI Technology
- Exchange
- ROIV Nasdaq
- NVMI Nasdaq
- Market Cap
- ROIV 8.6B
- NVMI 6.9B
- IPO Year
- ROIV N/A
- NVMI 2000
- Fundamental
- Price
- ROIV $14.08
- NVMI $293.10
- Analyst Decision
- ROIV Strong Buy
- NVMI Strong Buy
- Analyst Count
- ROIV 4
- NVMI 5
- Target Price
- ROIV $15.50
- NVMI $282.50
- AVG Volume (30 Days)
- ROIV 6.6M
- NVMI 477.7K
- Earning Date
- ROIV 11-11-2025
- NVMI 11-06-2025
- Dividend Yield
- ROIV N/A
- NVMI N/A
- EPS Growth
- ROIV N/A
- NVMI 52.61
- EPS
- ROIV N/A
- NVMI 7.36
- Revenue
- ROIV $23,233,000.00
- NVMI $807,085,000.00
- Revenue This Year
- ROIV N/A
- NVMI $32.36
- Revenue Next Year
- ROIV $281.14
- NVMI $7.31
- P/E Ratio
- ROIV N/A
- NVMI $39.81
- Revenue Growth
- ROIV N/A
- NVMI 43.69
- 52 Week Low
- ROIV $8.73
- NVMI $154.00
- 52 Week High
- ROIV $14.48
- NVMI $296.66
- Technical
- Relative Strength Index (RSI)
- ROIV 76.40
- NVMI 64.33
- Support Level
- ROIV $11.85
- NVMI $232.73
- Resistance Level
- ROIV $14.48
- NVMI $281.16
- Average True Range (ATR)
- ROIV 0.42
- NVMI 9.47
- MACD
- ROIV 0.21
- NVMI 4.37
- Stochastic Oscillator
- ROIV 86.26
- NVMI 94.44
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About NVMI Nova Ltd.
Nova Ltd is a semiconductor equipment manufacturer. The company provides metrology solutions for process control used in semiconductor manufacturing. The company offers in-line optical and x-ray stand-alone metrology systems, as well as integrated optical metrology systems. The product range consists of Nova 2040, Nova 3090Next, Nova i500 and i500 Plus, Nova T500, Nova T600, Nova V2600, HelioSense 100, Nova Hybrid Metrology solution, NovaMars. The company generates the majority of its revenue from China. Geographically the company has its business spread across the region of Taiwan, Korea, China, the United States, and Europe.